losartan has been researched along with Hypermobility, Joint in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mehta, P | 1 |
| Holder, SE | 1 |
| Fisher, B | 1 |
| Vincent, TL | 1 |
1 other study available for losartan and Hypermobility, Joint
| Article | Year |
|---|---|
A late presentation of Loeys-Dietz syndrome: joint hypermobility is not always benign.
Topics: Angiotensin II Type 1 Receptor Blockers; Aortic Aneurysm, Abdominal; Comorbidity; Female; Humans; Jo | 2014 |